About SR One
SR One is a Healthcare company. A biotechnology venture capital firm investing in innovative science. It operates in the Healthcare and Financial Services sectors. SR One offers products and services including Venture Capital Investments and Portfolio Management Services. Its focus areas include Innovation, Drug Development, Therapeutics and Biotechnology. Its legal entity is SR One Capital Management.
Company details
SR One is described as a biotechnology venture capital firm that partners with founders to facilitate the translation of innovative science into medicines. A back-and-build approach is employed by SR One, emphasizing companies with strong fundamentals and defined development pathways for addressing diseases. The firms transatlantic presence, including offices in the United States and United Kingdom, is utilized to provide strategic support and access high-quality opportunities across geographies. Investments are made to reimagine current science for future medical advancements, with a focus on real-time business assistance for portfolio companies. Regulatory disclosures and privacy policies are maintained as part of its operations.
- SectorsHealthcareFinancial Services
- Email••••••••
- Social LinkedIn
- Legal Name Sr One Capital Management
Products & Services of SR One
SR One offers a comprehensive portfolio of products and services, including Venture Capital Investments and Portfolio Management Services.
Investments are made in biotechnology firms to support the development of innovative medicines.
Management is offered for a portfolio of companies focused on novel disease approaches and scientific innovation.
People of SR One
26 people are tracked at SR One (12 in leadership, 14 in team).
| Name | Role | Group |
|---|---|---|
Simeon George | Chief Executive Officer And Co-founder | Leadership |
Rajeev Dadoo | Managing Partner | Leadership |
Peter Van Vlasselaer | Venture Partner | Leadership |
James Macadam | Chief Financial Officer | Leadership |
Karen Narolewski Engel | VP Operations | Leadership |
Jill Carroll | Partner | Leadership |
Chris Chai | Venture Partner | Leadership |
Sasha Keough | General Counsel & Chief Compliance Officer | Leadership |
Jake Nunn | Partner | Leadership |
Jake Bauer | Venture Partner | Leadership |
Iqbal Mufti | Venture Partner | Leadership |
Philip Habib | Head Of Capital Formation | Leadership |
Frances Benson | Executive Assistant | Team |
Janet Mastrocola | Executive Assistant | Team |
Daanish Jamal | Senior Associate | Team |
Matthew Foy | Senior Advisor | Team |
Myriam Belghiti | Intern | Team |
Tanya McGlashan | Executive Assistant | Team |
Mahesh Kudari | Biotech Venture Capital | Team |
Laetitia Schwab | Senior Associate | Team |
6 more people are available in the full profile.
Complete people profiles for SR One
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sr One
Complete news archive for SR One
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SR One
SR One is described as a biotechnology venture capital firm that partners with founders to facilitate the translation of innovative science into medicines. A back-and-build approach is employed by SR One, emphasizing companies with strong fundamentals and defined development pathways for addressing diseases. The firms transatlantic presence, including offices in the United States and United Kingdom, is utilized to provide strategic support and access high-quality opportunities across geographies. Investments are made to reimagine current science for future medical advancements, with a focus on real-time business assistance for portfolio companies. Regulatory disclosures and privacy policies are maintained as part of its operations.
SR One offers Venture Capital Investments and Portfolio Management Services.
SR One operates through Sr One Capital Management.